GlassScriptPhysician profile
Joseph S Scheidler
NPI 1679795041
$11,424.23
in general payments reported to CMS, 2019-2025
16 companies · $3,262 in 2025
The $3,262 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,858 · 2020: $542 · 2021: $15.94 · 2022: $1,223 · 2023: $677 · 2024: $3,846 · 2025: $3,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,636 · Food and Beverage: $3,138 · Education: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,635.61 |
| Food and Beverage | $3,138.01 |
| Education | $1,011.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,327.06 | 2020-2025 | Persona, Avenir, Comprehensive Shoulder System |
| Cdc Medical LLC | $1,204.06 | 2019-2024 | |
| Osteomed LLC | $1,000.00 | 2019 | |
| Arthrex, INC. | $970.30 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2020 | |
| Amgen INC. | $124.30 | 2023 | Repatha |
| Legacy Ortho LLC | $114.64 | 2025 | |
| Stryker Corporation | $105.27 | 2022-2025 | Variax, Asnis |
| Idorsia Pharmaceuticals US INC | $100.46 | 2023 | Quviviq |
| Amarin Pharma, INC. | $90.86 | 2019 | |
| Ethicon US, LLC | $86.34 | 2025 | Vistaseal, Dermabond Prineo |
| Celgene Corporation | $82.55 | 2019 | |
| Vericel Corporation | $42.74 | 2022-2023 | Maci |
| Abbvie INC. | $17.89 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.82 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $15.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Scheidler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.